BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 7905610)

  • 1. Neuroprotection with NBQX and thrombolysis with rt-PA in rat embolic stroke.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    Neurol Res; 1993 Oct; 15(5):344-9. PubMed ID: 7905610
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhancing the efficacy of thrombolysis by AMPA receptor blockade with NBQX in a rat embolic stroke model.
    Meden P; Overgaard K; Sereghy T; Boysen G
    J Neurol Sci; 1993 Nov; 119(2):209-16. PubMed ID: 8277337
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reduction of infarct volume and mortality by thrombolysis in a rat embolic stroke model.
    Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
    Stroke; 1992 Aug; 23(8):1167-73; discussion 1174. PubMed ID: 1636193
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Neuroprotection by excitatory amino acid antagonist augments the benefit of thrombolysis in embolic stroke in rats.
    Sereghy T; Overgaard K; Boysen G
    Stroke; 1993 Nov; 24(11):1702-8. PubMed ID: 8236347
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of delayed thrombolysis with rt-PA in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    J Cereb Blood Flow Metab; 1994 May; 14(3):472-7. PubMed ID: 8163589
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of infarct volume by thrombolysis with rt-PA in an embolic rat stroke model.
    Overgaard K; Sereghy T; Boysen G; Pedersen H; Diemer NH
    Scand J Clin Lab Invest; 1993 Jul; 53(4):383-93. PubMed ID: 8378742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A new rat model of thrombotic focal cerebral ischemia.
    Zhang Z; Zhang RL; Jiang Q; Raman SB; Cantwell L; Chopp M
    J Cereb Blood Flow Metab; 1997 Feb; 17(2):123-35. PubMed ID: 9040491
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diffusion-, T2-, and perfusion-weighted nuclear magnetic resonance imaging of middle cerebral artery embolic stroke and recombinant tissue plasminogen activator intervention in the rat.
    Jiang Q; Zhang RL; Zhang ZG; Ewing JR; Divine GW; Chopp M
    J Cereb Blood Flow Metab; 1998 Jul; 18(7):758-67. PubMed ID: 9663506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The influence of body temperature on infarct volume and thrombolytic therapy in a rat embolic stroke model.
    Meden P; Overgaard K; Pedersen H; Boysen G
    Brain Res; 1994 May; 647(1):131-8. PubMed ID: 8069695
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response of rt-PA and its combination with aspirin in a rat embolic stroke model.
    Overgaard K; Sereghy T; Pedersen H; Boysen G
    Neuroreport; 1992 Oct; 3(10):925-8. PubMed ID: 1421100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of citicoline combined with thrombolytic therapy in a rat embolic stroke model.
    Andersen M; Overgaard K; Meden P; Boysen G; Choi SC
    Stroke; 1999 Jul; 30(7):1464-71. PubMed ID: 10390324
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Increased therapeutic efficacy with rt-PA and anti-CD18 antibody treatment of stroke in the rat.
    Zhang RL; Zhang ZG; Chopp M
    Neurology; 1999 Jan; 52(2):273-9. PubMed ID: 9932943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of hypothermia and delayed thrombolysis in a rat embolic stroke model.
    Meden P; Overgaard K; Pedersen H; Boysen G
    Acta Neurol Scand; 1994 Aug; 90(2):91-8. PubMed ID: 7801745
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reperfusion after thrombolytic therapy of embolic stroke in the rat: magnetic resonance and biochemical imaging.
    Busch E; Krüger K; Allegrini PR; Kerskens CM; Gyngell ML; Hoehn-Berlage M; Hossmann KA
    J Cereb Blood Flow Metab; 1998 Apr; 18(4):407-18. PubMed ID: 9538906
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of intra-arterial and intravenous prourokinase in an embolic stroke model evaluated by diffusion-perfusion magnetic resonance imaging.
    Takano K; Carano RA; Tatlisumak T; Meiler M; Sotak CH; Kleinert HD; Fisher M
    Neurology; 1998 Apr; 50(4):870-5. PubMed ID: 9566365
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Delayed tissue-plasminogen activator therapy in a rabbit model of thromboembolic stroke.
    Gross CE; Raymond SJ; Howard DB; Bednar MM
    Neurosurgery; 1995 Jun; 36(6):1172-7. PubMed ID: 7643999
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Thrombolytic therapy in experimental embolic stroke.
    Overgaard K
    Cerebrovasc Brain Metab Rev; 1994; 6(3):257-86. PubMed ID: 7811566
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early (1 h) administration of tissue plasminogen activator reduces infarct volume without increasing hemorrhagic transformation after focal cerebral embolization in rats.
    Zhang RL; Chopp M; Zhang ZG; Divine G
    J Neurol Sci; 1998 Sep; 160(1):1-8. PubMed ID: 9804110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Application of albumin prior to delayed thrombolysis reduces brain edema and blood brain barrier permeability in an embolic stroke model.
    Lu HT; Zhao JG; Li MH; Li YD
    Brain Res; 2012 Feb; 1438():75-84. PubMed ID: 22227456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Monteplase reduces infarct volume and hemorrhagic transformation in rat model of embolic stroke.
    Muramatsu H; Igarashi H; Okubo S; Katayama Y
    Neurol Res; 2002 Apr; 24(3):311-6. PubMed ID: 11958428
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.